We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Hyperuricemia and Insulin Resistance: Interplay and Potential for Targeted Therapies
PeriodicalsMedical Sciences

Hyperuricemia and Insulin Resistance: Interplay and Potential for Targeted Therapies

Checking your access to this record.

Abstract & Overview

Hyperuricemia, defined as elevated serum uric acid (SUA) levels (>6.8 mg/dL), is traditionally linked to gout and nephrolithiasis but is increasingly implicated in insulin resistance (IR) and type 2 diabetes mellitus (T2DM). Epidemiological studies, such as NHANES, suggest hyperuricemia increases the risk of T2DM by 1.6 to 2.5 times. Mechanistically, uric acid promotes IR via oxidative stress, chronic inflammation, endothelial dysfunction, and adipocyte dysregulation. Despite growing evidence, significant gaps remain in understanding these pathways, with existing studies often limited by observational designs and short intervention durations. A bibliographic analysis of studies from 2004–2024 using Web of Science and VOSviewer highlights a growing focus on hyperuricemia’s interplay with inflammation, oxidative stress, and metabolic disorders. However, inconsistencies in therapeutic outcomes and limited exploration of causality underscore the need for further research. We also explored the importance of gender stratification and the limitations of the binary model for the relationship between hyperuricemia and insulin resistance. This review emphasizes the importance of addressing these gaps to optimize hyperuricemia management as a potential strategy for diabetes prevention and metabolic health improvement.

Cite this record

Opeyemi O. Deji-Oloruntoba, James Onoruoiza Balogun, Taiwo Olayemi Elufioye, Simeon Okechukwu Ajakwe (2025). Hyperuricemia and Insulin Resistance: Interplay and Potential for Targeted Therapies. International Journal of Translational Medicine, 5(3), 30–30. https://doi.org/10.3390/ijtm5030030

Copy in another style

Deji-Oloruntoba, O. O., Balogun, J. O., Elufioye, T. O., & Ajakwe, S. O. (2025). Hyperuricemia and Insulin Resistance: Interplay and Potential for Targeted Therapies. International Journal of Translational Medicine, 5(3), 30–30. https://doi.org/10.3390/ijtm5030030
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.